Skip to content

Clinical trials

Phase 2 Ischemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemia Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20054
20061
20071
20092
20113
20151
20162
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
AnGes USA, Inc.2
Aldagen1
Astellas Pharma Inc1
Dart NeuroScience, LLC1
HonorHealth Research Institute1
Johns Hopkins University1
Lantheus Medical Imaging1
Medicure1
Penumbra Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemia21
Stroke7
Coronary Artery Disease6
Ischemic Stroke5
Peripheral Vascular Diseases4
Chronic Limb-Threatening Ischemia3
Arterial Occlusive Diseases2
Atherosclerosis2
Cardiovascular Diseases2
Coronary Disease2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.